Abbott Laboratories's total assets for Q3 2024 were $74.36B, an increase of 1.83% from the previous quarter. DE:ABL total liabilities were $34.33B for the fiscal quarter, a 2.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.